The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Methylphenidate improves prefrontal cortical cognitive function through α2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder
Open accessAbstract
Background: Methylphenidate (MPH) is the classic treatment for Attention Deficit Hyperactivity Disorder (ADHD), yet the mechanisms underlying its therapeutic actions remain unclear. Recent studies have identified an oral, MPH dose regimen which when given to rats produces drug plasma levels similar to those measured in humans. The current study examined the effects of these low, orally-administered doses of MPH in rats performing a delayed alternation task dependent on prefrontal cortex (PFC), a brain region that is dysfunctional in ADHD, and is highly sensitive to levels of catecholamines. The receptor mechanisms underlying the enhancing effects of MPH were explored by challenging the MPH response with the noradrenergic α2 adrenoceptor antagonist, idazoxan, and the dopamine D1 antagonist, SCH23390. Results: MPH produced an inverted U dose response whereby moderate doses (1.0–2.0 mg/kg, p.o.) significantly improved delayed alternation performance, while higher doses (2.0–3.0 mg/kg, p.o.) produced perseverative errors in many animals. The enhancing effects of MPH were blocked by co-administration of either the α2 adrenoceptor antagonist, idazoxan, or the dopamine D1 antagonist, SCH23390, in doses that had no effect on their own. Conclusion: The administration of low, oral doses of MPH to rats has effects on PFC cognitive function similar to those seen in humans and patients with ADHD. The rat can thus be used as a model for examination of neural mechanisms underlying the therapeutic effects of MPH on executive functions in humans. The efficacy of idazoxan and SCH23390 in reversing the beneficial effects of MPH indicate that both noradrenergic α2 adrenoceptor and dopamine D1 receptor stimulation contribute to cognitive-enhancing effects of MPH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lower doses in rats improve PFC attention and working memory function, enhance PFC neuronal response, and reduce locomotor hyperactivity in juveniles (Arnsten and Dudley, 2005; Berridge et al., 2006; Kuczenski and Segal, 2002).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Arnsten and Dudley, 2005
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Animal studies have shown that therapeutic doses of methylphenidate and atomoxetine improve PFC function by increasing endogenous NE stimulation of α2-receptors and DA stimulation of D1-receptors in rats (Arnsten and Dudley, 2005) and monkeys (Gamo et al., 2010).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Arnsten and Dudley, 2005
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Our study reveals that stimulants may upregulate neuroimaging activation patterns in the left cerebellum compared to controls given their indirect phosphorylation of the glutamate receptor through modulating the release of norepinephrine”
From Overlapping and differential neuropharmacological mechanisms of stimulants and nonstimulants for attention-deficit/hyperactivity disorder: A comparative neuroimaging analysis (2024) · cites this paper as Arnsten & Dudley, 2005
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This observation is in line with previous research demonstrating that children with ADHD tend to show impaired planning abilities (e.g., Clarke, Prior, & Kinsella, 2000) that can be restored with MPH (e.g., Arnsten & Dudley, 2005).”
From Implementation Intentions Facilitate Response Inhibition in Children with ADHD (2008) · cites this paper as Arnsten & Dudley, 2005
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Further, recent physiological studies have shown that NE strengthens network connectivity of the PFC and maintains persistent firing of PFC neurons during working memory tasks through stimulation of postsynaptic α2-adrenoceptors (Arnsten and Dudley, 2005).”
From The Effects of Methylphenidate on Goal-directed Behavior in a Rat Model of ADHD (2015) · cites this paper as Arnsten and Dudley, 2005
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“When administered in appropriate doses, these medications improve PFC function both in healthy human subjects (Elliott et al., 1997) and in animals (Arnsten and Dudley, 2005), including the reduction of locomotor hyperactivity in juvenile rats (Kuczenski and Segal, 2002).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Arnsten and Dudley, 2005
The cited source says what the claim attributes to it.
In the citing paper
“This article reviews studies in animals showing that norepinephrine and dopamine enhance PFC function through actions at postsynaptic α2A-adrenoceptors and dopamine D1-receptors, respectively.”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Arnsten and Dudley, 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of Frontal Lobe Function
Stuss, D. T. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134971.001.0001 · Cited by 1,731
Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey
Brozoski, T. J., Brown, R. M., Rosvold, H. E., & Goldman, P. S. (1979) · Science · doi:10.1126/science.112679 · Cited by 1,500
D1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory
Sawaguchi, T., & Goldman-Rakic, P. S. (1991) · Science · doi:10.1126/science.1825731 · Cited by 1,364
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123
Goldman-Rakic, P. S. (1996) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1996.0129 · Cited by 1,072
Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions
Arnsten, A. F. T., & Li, B.-M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.019 · Cited by 948
Self-citationVaidya, C. J., Austin, G., Kirkorian, G., Ridlehuber, H. W., Desmond, J. E., Glover, G. H., & Gabrieli, J. D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14494 · Cited by 845
(1964) · McGraw-Hill eBooks · Cited by 838
Zahrt, J., Taylor, J. R., Mathew, R. G., & Arnsten, A. F. T. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-21-08528.1997 · Cited by 796
Self-citationBarkley, R. A., Grodzinsky, G., & DuPaul, G. J. (1992) · Journal of Abnormal Child Psychology · doi:10.1007/bf00916547 · Cited by 724
Flagged first, then by citations
Research works printed but not linked: 1
- Arnsten AFT, Castellanos FX: Neurobiology of attention regulation and its disorders. Textbook of Child and Adolescent Psychopharmacology. Edited by: Martin A, Scahill L, Charney D and Leckman J. 2002, NY, Oxford Univ. Press, 99-109.
Cited by
Sorted by citations
Items 101–200 of 365
Rowley, H. L., Kulkarni, R. S., Gosden, J., Brammer, R. J., Hackett, D., & Heal, D. J. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881113513850 · Cited by 65
Rowley, H. L., Kulkarni, R., Gosden, J., Brammer, R., Hackett, D., & Heal, D. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.008 · Cited by 64
Sallee, F. R., Connor, D. F., & Newcorn, J. H. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2013.0028 · Cited by 64
Visual attention: Linking prefrontal sources to neuronal and behavioral correlates
Clark, K., Squire, R. F., Merrikhi, Y., & Noudoost, B. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.06.006 · Cited by 64
Creativity in ADHD: Goal-Directed Motivation and Domain Specificity
Boot, N. C., Nevicka, B., & Baas, M. (2017) · Journal of Attention Disorders · doi:10.1177/1087054717727352 · Cited by 91
Johnson, K. A., Barry, E., Bellgrove, M. A., Cox, M., Kelly, S. P., Dáibhis, A., Daly, M., Keavey, M., Watchorn, A., Fitzgerald, M., et al. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2008.01.002 · Cited by 62
Padala, P. R., Boozer, E. M., Lensing, S., Parkes, C. M., Hunter, C. R., Dennis, R. A., Cáceda, R., & Padala, K. P. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200640 · Cited by 65
Brain γ‐aminobutyric acid: a neglected role in impulsivity
Hayes, D. J., Jupp, B., Sawiak, S. J., Merlo, E., Caprioli, D., & Dalley, J. W. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12485 · Cited by 67
Noninvasive Brain Stimulation in Pediatric Attention-Deficit Hyperactivity Disorder (ADHD)
Rubio, B., Boes, A. D., Laganiere, S. E., Rotenberg, A., Jeurissen, D., & Pascual‐Leone, Á. (2015) · Journal of Child Neurology · doi:10.1177/0883073815615672 · Cited by 64
Yang, L., Cao, Q., Shuai, L., Li, H., Chan, R. C. K., & Wang, Y. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001490 · Cited by 63
Abraham, A. D., Neve, K. A., & Lattal, K. M. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.5 · Cited by 59
Distinct Age-Dependent Effects of Methylphenidate on Developing and Adult Prefrontal Neurons
Urban, K. R., Waterhouse, B. D., & Gao, W. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.04.018 · Cited by 57
McCracken, J. T., McGough, J. J., Loo, S. K., Levitt, J., Del’Homme, M., Cowen, J., Sturm, A., Whelan, F., Hellemann, G., Sugar, C., et al. (2016) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2016.05.015 · Cited by 57
Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe
Huß, M., Chen, W., & Ludolph, A. G. (2015) · Clinical Drug Investigation · doi:10.1007/s40261-015-0336-0 · Cited by 60
Pharmacological and therapeutic directions in ADHD: Specificity in the PFC
Lévy, F. (2008) · Behavioral and Brain Functions · doi:10.1186/1744-9081-4-12 · Cited by 58
Performance Enhancing, Non-Prescription Use of Ritalin
Svetlov, S. I., Kobeissy, F. H., & Gold, M. S. (2007) · Journal of Addictive Diseases · doi:10.1300/j069v26n04_01 · Cited by 56
From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate
Busardò, F. P., Kyriakou, C., Cipolloni, L., Zaami, S., & Frati, P. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666150407225902 · Cited by 59
Hao, J., Beck, J. P., Schaus, J. M., Krushinski, J. H., Chen, Q., Beadle, C. D., Vidal, P., Reinhard, M. R., Dressman, B. A., Massey, S. M., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01234 · Cited by 56
Genetic associations with reflexive visual attention in infancy and childhood
Lundwall, R. A., Dannemiller, J. L., & Goldsmith, H. H. (2015) · Developmental Science · doi:10.1111/desc.12371 · Cited by 54
ADHD pharmacogenetics across the life cycle: New findings and perspectives
Bruxel, E. M., Akutagava-Martins, G. C., Salatino-Oliveira, A., Contini, V., Kieling, C., Hutz, M., & Rohde, L. (2014) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32240 · Cited by 44
Yang, P. B., Swann, A. C., & Dafny, N. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.04.014 · Cited by 51
da Silva, T. L., Pianca, T. G., Roman, T., Hutz, M. H., Faraone, S. V., Schmitz, M. D., & Rohde, L. A. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-007-0835-0 · Cited by 51
Yang, P. B., Swann, A. C., & Dafny, N. (2006) · Behavioral and Brain Functions · doi:10.1186/1744-9081-2-3 · Cited by 51
Cao, A., Yu, L., Wang, Y., Wang, J.-M., Yang, L., & Lei, G.-F. (2012) · Behavioral and Brain Functions · doi:10.1186/1744-9081-8-10 · Cited by 52
Barak, S., & Weiner, I. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.03.011 · Cited by 51
Chase, T. D., CARREY, N. J., Soo, E. C., & Wilkinson, M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.10.035 · Cited by 51
The Development of the Mesoprefrontal Dopaminergic System in Health and Disease
Islam, K. U. S., Meli, N., & Blaess, S. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.746582 · Cited by 55
Carboni, E., Barros, V. G., Ibba, M., Silvagni, A., Mura, C., & Antonelli, M. C. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.03.046 · Cited by 49
Urban, K. R., Li, Y., & Gao, W. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.01.004 · Cited by 51
The Role of Nutritional Supplements in the Treatment of ADHD: What the Evidence Says
Lange, K. W., Hauser, J., Lange, K. M., Makulska-Gertruda, E., 中村由紀子, Reißmann, A., Sakaue, Y., Takano, T., & Takeuchi, Y. (2017) · Current Psychiatry Reports · doi:10.1007/s11920-017-0762-1 · Cited by 51
Riccardi, P., Park, S., Anderson, S. A., Doop, M., Ansari, M., Schmidt, D., & Baldwin, R. (2011) · Synapse · doi:10.1002/syn.20822 · Cited by 46
Pattij, T., Schetters, D., Schoffelmeer, A. N. M., & van Gaalen, M. M. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2405-2 · Cited by 47
Faraone, S. V., McBurnett, K., Sallee, F. R., Steeber, J., & López, F. A. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.09.005 · Cited by 44
Rodenkirch, C., Carmel, J. B., & Wang, Q. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.922424 · Cited by 42
Cheon, K.-A. A., Jun, J.-Y., & Cho, D.-Y. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328306a977 · Cited by 45
Del’Guidice, T., Lemay, F., Lemasson, M., Levasseur‐Moreau, J., Manta, S., Etiévant, A., Escoffier, G., Doré, F. Y., Roman, F. S., & Beaulieu, J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.313 · Cited by 41
Luderman, K. D., Conroy, J., Free, R. B., Southall, N. T., Ferrer, M., Sánchez‐Soto, M., Moritz, A. E., Willette, B. K. A., Fyfe, T. J., Jain, P., et al. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.113175 · Cited by 45
Fallu, A., Richard, C., Prinzo, R., & Binder, C. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x154132 · Cited by 42
Zhang, C.-L., Feng, Z.-J., Liu, Y., Ji, X.-H., Peng, J.-Y., Zhang, X.-H., Zhen, X.-C., & Li, B.-M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051910 · Cited by 41
Methylphenidate improves performance on the radial arm maze in periadolescent rats
Dow-Edwards, D. L., Weedon, J. C., & Hellmann, E. (2008) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2008.04.001 · Cited by 41
Zhang, T., Hong, J., Di, T., & Chen, L. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00101 · Cited by 39
Schmeichel, B. E., Zemlan, F. P., & Berridge, C. W. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.005 · Cited by 40
Philipsen, M. H., Phan, N. T. N., Fletcher, J. S., Malmberg, P., & Ewing, A. G. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00046 · Cited by 38
Beaudin, S. A., Strupp, B. J., Lasley, S. M., Fornal, C. A., Mandal, S., & Smith, D. R. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv007 · Cited by 38
Monoaminergic modulation of behavioural and electrophysiological indices of error processing
Barnes, J. J. M., O’Connell, R. G., Nandam, L. S., Dean, A. J., & Bellgrove, M. A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3246-y · Cited by 38
Swearingen, D., Pennick, M., Shojaei, A., Lyne, A., & Fiske, K. S. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.04.016 · Cited by 38
Robison, L. S., Michaelos, M., Gandhi, J., Fricke, D., Miao, E., Lam, C.-Y., Mauceri, A., Vitale, M., Lee, J., Paeng, S., et al. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00053 · Cited by 39
Coelho‐Santos, V., Cardoso, F. L., Leitão, R. A., Ribeiro, C., & Silva, A. P. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.10.016 · Cited by 39
Animal model of methylphenidate's long-term memory-enhancing effectsPreprint
Carmack, S., Howell, K. K., Rasaei, K., Reas, E. T., & Anagnostaras, S. (2014) · Learning & Memory · doi:10.1101/lm.033613.113 · Cited by 41
Jones, Z., & Dafny, N. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-013-1101-2 · Cited by 37
Conley, T. E., Beaudin, S. A., Lasley, S. M., Fornal, C. A., Hartman, J., Uribe, W., Khan, T., Strupp, B. J., & Smith, D. R. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14934 · Cited by 38
The Role of Alpha2-Adrenergic Agonists in Attention-Deficit/Hyperactivity Disorder
Sallee, F. R. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.09.2204 · Cited by 36
Marta Ribasés, A., Ramos‐Quiroga, J. A., Amaia Hervas, G., Sánchez‐Mora, C., Bosch, R., Bielsa, A., Gastaminza, X., Lesch, K., Reif, A., Renner, T., et al. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.584905 · Cited by 37
Peña, I. D., & Cheong, J. H. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0037-2 · Cited by 35
Contreras, D., Piña, R., Carvallo, C., Godoy, F., Ugarte, G., Zeise, M., Rozas, C., & Morales, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137099 · Cited by 35
Prehn‐Kristensen, A., Krauel, K., Hinrichs, H., Fischer, J., Malecki, U., Schuetze, H., Wolff, S., Jansen, O., Düzel, E., & Baving, L. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.075 · Cited by 37
Konstantoudaki, X., Chalkiadaki, K., Vasileiou, E., Kalemaki, K., Karagogeos, D., & Sidiropoulou, K. (2017) · Journal of Neurophysiology · doi:10.1152/jn.00189.2017 · Cited by 36
Stevens, T., Sangkuhl, K., Brown, J. T., Altman, R. B., & Klein, T. E. (2019) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000376 · Cited by 37
Cortical dopamine reduces the impact of motivational biases governing automated behaviour
Scholz, V., Hook, R. W., Kandroodi, M. R., Algermissen, J., Ioannidis, K., Christmas, D. M., Valle, S., Robbins, T. W., Grant, J. E., Chamberlain, S. R., et al. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01291-8 · Cited by 32
Chong, S. L., Claussen, C. M., & Dafny, N. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.01.004 · Cited by 34
Effects of methylphenidate on reinforcement learning depend on working memory capacity
Kandroodi, M. R., Cook, J. L., Swart, J. C., Froböse, M. I., Geurts, D. E. M., Vahabie, A., Ahmadabadi, M. N., Cools, R., & den Ouden, H. E. M. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05974-w · Cited by 39
Treatment of adults with attention-deficit/hyperactivity disorder
Hechtman, L. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s1747 · Cited by 31
Correlates and Clinical Implications of Tic Suppressibility
Ueda, K., Kim, S., Greene, D. J., & BLACK, K. J. (2021) · Current Developmental Disorders Reports · doi:10.1007/s40474-021-00230-4 · Cited by 31
Moses, M., Tiego, J., Demontis, D., Bragi Walters, G., Stefansson, H., Stefansson, K., Børglum, A. D., Arnatkeviciute, A., & Bellgrove, M. A. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01775-5 · Cited by 31
Oral methylphenidate improves spatial learning and memory in pre- and periadolescent rats.
Zhu, N. W., Weedon, J., & Dow-Edwards, D. L. (2007) · Behavioral Neuroscience · doi:10.1037/0735-7044.121.6.1272 · Cited by 31
Noradrenaline involvement in basic and higher integrated REM sleep processes
Gottesmann, C. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.04.002 · Cited by 33
El-Hassar, L., Simen, A. A., Duque, A., Patel, K. D., Kaczmarek, L. K., Arnsten, A. F. T., & Yeckel, M. F. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.12.019 · Cited by 30
Self-citationReceptor and circuit mechanisms underlying differential procognitive actions of psychostimulants
Spencer, R. C., & Berridge, C. W. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0314-y · Cited by 31
A novel method for oral stimulant administration in the neonate rat and similar species
Wheeler, T. L., Eppolito, A. K., Smith, L. N., Huff, T. B., & Smith, R. F. (2006) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2006.07.019 · Cited by 31
Reprint of “Neurobiology of animal models of attention-deficit hyperactivity disorder”
Russell, V. A. (2007) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2006.12.020 · Cited by 29
Lobeline Effects on Cognitive Performance in Adult ADHD
Martin, C. A., Nuzzo, P. A., Ranseen, J. D., Kleven, M. S., Guenthner, G., Williams, Y. S., WALSH, S. L., & Dwoskin, L. P. (2013) · Journal of Attention Disorders · doi:10.1177/1087054713497791 · Cited by 28
Attention Deficit Hyperactivity Disorder (ADHD) and the gut microbiome: An ecological perspective
Cickovski, T., Mathee, K., Aguirre, G., Tatke, G., Hermida, A., Narasimhan, G., & Stollstorff, M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0273890 · Cited by 35
Adrenergic α2A receptor gene is not associated with methylphenidate response in adults with ADHD
Contini, V., Victor, M. M., de Cerqueira, C. C. S., Polina, E. R., Grevet, E. H., Salgado, C. A. I., Karam, R. G., Vitola, E. S., Belmonte-de-Abreu, P. S., & Bau, C. H. D. (2010) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-010-0172-4 · Cited by 28
Medication and creativity in Attention Deficit Hyperactivity Disorder (ADHD)
Hernández, G. G.-C., & Selva, J. S. (2016) · Psicothema · doi:10.7334/psicothema2015.126 · Cited by 33
Muñoz‐Villegas, P., Rodríguez, V. M., Giòrdano, M., & Juárez, J. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.12.011 · Cited by 27
Bensmann, W., Zink, N., Roessner, V., Stock, A., & Beste, C. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119827815 · Cited by 28
From neurons to brain networks, pharmacodynamics of stimulant medication for ADHD
Parlatini, V., Bellato, A., Murphy, D., & Cortese, S. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105841 · Cited by 26
Jan, R. K., Lin, J. C., McLaren, D. G., Kirk, I. J., Kydd, R. R., & Russell, B. R. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00020 · Cited by 26
Hoeppner, J., Wandschneider, R., Neumeyer, M., Gierow, W., Haessler, F., Herpertz, S. C., & Buchmann, J. A. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-007-0008-1 · Cited by 26
Andrzejewski, M. E., Spencer, R. C., Harris, R. L., Feit, E. C., McKee, B. L., & Berridge, C. W. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.018 · Cited by 24
Humpston, C. S., Wood, C. M., & Robinson, E. S. J. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112466182 · Cited by 26
Martin, C. D., Fricke, D., Vijayashanthar, A., Lowinger, C., Koutsomitis, D., Popoola, D. O., Hadjiargyrou, M., Komatsu, D. E., & Thanos, P. K. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.07.001 · Cited by 25
The Involvement of Noradrenaline in Rapid Eye Movement Sleep Mentation
Gottesmann, C. (2011) · Frontiers in Neurology · doi:10.3389/fneur.2011.00081 · Cited by 25
Sagvolden, T. (2011) · Behavioral and Brain Functions · doi:10.1186/1744-9081-7-6 · Cited by 25
Differential long-term medication impact on executive function and delay aversion in ADHD
Morell, B. R., & Expósito, S. H. (2017) · Applied Neuropsychology Child · doi:10.1080/21622965.2017.1407653 · Cited by 24
Investigation of the G protein subunit Gαolf gene (GNAL) in attention deficit/hyperactivity disorder
Laurin, N., Ickowicz, A., Pathare, T., MALONE, M. A., Tannock, R., Schachar, R. J., Kennedy, J. L., & Barr, C. L. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.10.010 · Cited by 24
Elsayed, N. A., Yamamoto, K. M., & Froehlich, T. E. (2020) · CNS Drugs · doi:10.1007/s40263-020-00702-y · Cited by 23
Berridge, C., & Arnsten, A. (2015) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2015.01.002 · Cited by 24
Self-citationClaussen, C. M., Chong, S. L., & Dafny, N. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.02.024 · Cited by 23
Defining the interconnectivity of the medial prefrontal cortex and ventral midbrain
Hui, M., & Beier, K. T. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.971349 · Cited by 25
Methylphenidate does not affect convergent and divergent creative processes in healthy adults
Baas, M., Boot, N. C., van Gaal, S., Dreu, C. K. W. D., & Cools, R. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.116279 · Cited by 22
Haleem, D. J., Inam, Q.-U.-A., & Haleem, M. A. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.12.031 · Cited by 23
Zhu, N. W., Weedon, J., & Dow-Edwards, D. L. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.12.004 · Cited by 22
Rajala, A. Z., Henriques, J. B., & Populin, L. C. (2012) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_00225 · Cited by 21
A role for cortical dopamine in the paradoxical calming effects of psychostimulants
Harris, S., Green, S. M., Kumar, M., & Urs, N. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-07029-2 · Cited by 23
Wilke, S. A., Johnson, C. L., Corlier, J., Marder, K. G., Wilson, A. C., Pleman, C. M., & Leuchter, A. F. (2022) · Depression and Anxiety · doi:10.1002/da.23255 · Cited by 22
Willmott, C., Ponsford, J. L., McAllister, T. W., & Burke, R. (2013) · Brain Injury · doi:10.3109/02699052.2013.809553 · Cited by 21
Urban, K. R., & Gao, W. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.09.009 · Cited by 20
Kohut, S. J., Fivel, P. A., & Mello, N. K. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.07.032 · Cited by 21
The Effects of Methylphenidate on Goal-directed Behavior in a Rat Model of ADHD
Natsheh, J. Y., & Shiflett, M. W. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00326 · Cited by 21
Metadata
- Authors
- Arnsten, A. F., & Dudley, A. G.
- Affiliations
- Yale University (US)
- Corresponding author
- Arnsten, Amy FT
- Venue
- Behavioral and Brain Functions
- Published
- 2005-04-22
- Volume
- 1
- Issue
- 1
- Pages
- 2-2
- ISSN
- 1744-9081 (ISSN-L)
- PMC
- PMC1143775
- OpenAlex
- W2124264649
- Cited by
- 363
- References
- 70
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 10 · 2023: 9 · 2022: 17 · 2021: 7 · 2020: 8 · 2019: 14 · 2018: 13 · 2017: 19 · 2016: 18 · 2015: 16 · 2014: 27 · 2013: 28 · 2012: 27
- FWCI
- 15.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Behavioral and Brain Functions (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Shire
- National Institutes of Health (5r21mh066393-03)
- National Institute of Mental Health (R21-MH066393)
- National Institute on Drug Abuse
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- methylphenidate, attention deficit hyperactivity disorder, prefrontal cortex, delayed alternation, executive function, alpha2-adrenoceptors, dopamine D1 receptor, idazoxan, SCH 23390, noradrenergic signaling, dopamine signaling, perseverative errors, dose-response relationship, rat model
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
